We look forward to 2 exciting presentations on day 4 of this year’s DDW in San Diego, USA: 

1. Eosinophilic esophagitis: results from the 96-weeks open-label extension phase on May 24, 2022 at 8:45 AM (local time, ID 881) and
2. Rectal budesonide formulations are well accepted by patients with ulcerative proctitis, improve work productivity and quality of life on May 24, 2022 at 12:30 pm (local time, ID 1473)

See you there!